Article Details

New Data Demonstrate Long-Term Benefit of IMBRUVICA® (ibrutinib) as First-Line Treatment for ...

Retrieved on: 2020-12-06 18:00:00

Tags for this article:

Click the tags to see associated articles and topics

New Data Demonstrate Long-Term Benefit of IMBRUVICA® (ibrutinib) as First-Line Treatment for .... View article details on hiswai:

Excerpt

New Data Demonstrate <b>Long</b>-<b>Term</b> Benefit of IMBRUVICA® (ibrutinib) as First-Line <b>Treatment</b> for High-Risk Chronic Lymphocytic Leukemia.

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up